Trial Profile
Botulinum Toxin A for the Treatment of Chemotherapy Induced Peripheral Neuropathy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Dec 2021
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Chemotherapy-induced damage; Neuropathic pain; Peripheral neuropathies
- Focus Therapeutic Use
- 21 Dec 2021 Planned End Date changed from 1 Aug 2021 to 31 Dec 2024.
- 21 Dec 2021 Planned primary completion date changed from 1 Jun 2021 to 31 Dec 2023.
- 08 Jul 2020 Planned End Date changed from 1 Aug 2020 to 1 Aug 2021.